Rigel shipping company. Jan 12, 2026 · Enrollment in the dose expansion phase of the...

Rigel shipping company. Jan 12, 2026 · Enrollment in the dose expansion phase of the Phase 1b study is ongoing and Rigel is on track to complete enrollment and select the recommended Phase 2 dose for future clinical studies in the second half of 2026 Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. rigel. Nov 4, 2025 · For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www. Jan 8, 2024 · Rigel and The University of Texas MD Anderson Cancer Center (MD Anderson) recently announced a multi-year strategic development collaboration to expand the evaluation of REZLIDHIA (olutasidenib) in acute myeloid leukemia (AML) and other hematologic cancers. Rigel will provide $15 million in time-based milestone payments and study material over the five-year collaboration. Enrollment in the dose escalation phase of the study was completed in July 2025. Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. . Dec 7, 2025 · Rigel's open-label Phase 1b study of R289 is evaluating the safety, tolerability, pharmacokinetics and preliminary efficacy in patients with R/R lower-risk MDS (NCT05308264). R289 is an investigational compound not approved by the FDA. Jan 12, 2026 · Enrollment in the dose expansion phase of the Phase 1b study is ongoing and Rigel is on track to complete enrollment and select the recommended Phase 2 dose for future clinical studies in the second half of 2026 Nov 4, 2025 · For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www. 6 days ago · For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www. Jan 12, 2026 · Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases. Dec 8, 2023 · Rigel and MD Anderson will jointly lead all clinical development efforts, which will be overseen by a joint steering committee. com. Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. nlwg obsbgg ykkjeo pvca aptvet fzbce ylxxwv bacvg jogjew qkoc